Loading news...
Angitia Biopharmaceuticals raised $46M Series B Plus venture round, led by Morningside Ventures.
This funding round does not have an about section yet.
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
MorningsideLEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$336M
Top Valuation
-
Angitia Biopharmaceuticals raised $46M in a Series B Plus round.
The round was announced on 10/25/23.
The round was led by Morningside Ventures.